Hunan Jiudian Pharmaceutical Co.Ltd(300705) independent director
Independent opinions on matters related to the 7th Meeting of the 3rd board of directors
In accordance with the Shenzhen Stock Exchange GEM Listing Rules, Shenzhen Stock Exchange self regulatory guidelines for listed companies No. 2 – standardized operation of GEM listed companies, guidance on the establishment of independent director system in listed companies, working rules for independent directors and other relevant laws, regulations and rules, As an independent director of Hunan Jiudian Pharmaceutical Co.Ltd(300705) (hereinafter referred to as “the company”), based on objective and independent judgment, we express independent opinions on relevant matters involved in the seventh meeting of the third board of directors as follows:
1、 Independent opinions on adjusting some investment projects with raised funds
The adjustment of some investment projects with raised funds is a prudent decision made according to the company’s development plan, actual operation, internal and external environment and other factors, which is in line with the company’s long-term development strategy and the actual situation of raised investment projects. The investment direction of raised funds has not been changed and will not have a substantive impact on the implementation of raised investment projects, There is no situation of changing the investment direction of the raised funds in a disguised form and damaging the interests of shareholders. This matter has fulfilled the necessary deliberation and decision-making procedures and complies with the relevant provisions of the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies, the Listing Rules of GEM stocks of Shenzhen Stock Exchange, and the guidelines for the self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of GEM listed companies. Therefore, we agree with the company to appropriately adjust the production capacity, some equipment, implementation location and construction cycle of the project invested with raised funds.
2、 Independent opinions on joint investment and related party transactions with professional investment institutions
The company’s investment can make full use of the professionalism and resource advantages of professional investment institutions, expand investment channels, reduce investment risks, promote the company’s industrial layout and improve its comprehensive competitiveness. There is no case that damages the interests of minority shareholders of the company. When the board of directors of the company considered the matter, the related directors avoided voting. The deliberation and voting procedures of the meeting met the relevant provisions of relevant laws, regulations and the articles of association, and the voting results were legal and effective. Therefore, we agree to this investment.
(there is no text below, and the next page is the signature page)
(there is no text on this page, which is the signature page of Hunan Jiudian Pharmaceutical Co.Ltd(300705) independent directors’ independent opinions on matters related to the seventh meeting of the third board of directors) signature of independent directors:
From Yangzhou to Linjing
